Ozempic. Mounjaro. Retatrutide. GLP-1s are completely changing the conversation around obesity, addiction, metabolic health, and weight loss. Some people think these drugs are one of the biggest breakthroughs in modern medicine. Others think we’re moving way too fast.

What made this conversation especially interesting for me is I’ve actually used GLP-1s with patients in bedside healthcare for almost 10 years throughout my nursing career, so it was cool being able to approach this from both a healthcare and real-world perspective. In this episode, Sheldon Martin and I break down how these drugs actually work, the diseases they’re changing, side effects, muscle loss, the underground peptide market, and we debunk some of the biggest conspiracies surrounding GLP-1s and peptides.